STC Number - 460

China's restrictions on imports of US beef

Maintained by: China
Raised by: United States of America
Supported by:
First date raised: July 2019 G/SPS/R/95 paras. 4.21-4.22
Dates subsequently raised:
Number of times subsequently raised: 0
Relevant documents: Raised orally.
Products covered: 0201 Meat of bovine animals, fresh or chilled.

Primary subject keyword: Animal Health
Keywords: Animal health; Food safety; Human health; Risk assessment; International Standards / Harmonization; Veterinary drugs; Bovine Spongiform Encephalopathy (BSE)
Status: Not reported
Date reported as resolved:

Extracts from SPS Committee meeting summary reports

In July 2019, the United States raised its continued concern with China's restrictions on US beef exports, despite China's recognition that the United States had negligible risk for BSE. The United States noted that current trade conditions with China fell short of full alignment with OIE recommendations for negligible risk countries. The United States continued to seek access for all products and the elimination of age and product scope restrictions, and requested China to align its import requirements regarding veterinary drugs, including beta agonists and hormones, with Codex standards.

China noted that after it had conducted a risk assessment and in June 2017 it had resumed imports of deboned and boned beef under 30 months of age from the United States. Since China had never been affected by BSE, it had not imported beef over 30 months of age from Members that had been affected by BSE, because cattle over 30 months of age had a higher risk of being infected with BSE, which increased the risk of BSE transmission. The measure was based on China's appropriate level of animal health protection and complied with the SPS Agreement. China remained interested in continuing consultations with the United States on the issue.